The recently launched SELECT cardiovascular outcomes trial is the first of its kindevaluating the cardiovascular benefits of weekly semaglutide in patients without diabetes but with a higher BMI (NCT03574597)
They can be expensive, and not all insurance plans provide coverage, causing patients to stop taking them
She's now suing prescription drugmaker Novo Nordisk, claiming its drug labels do not adequately warn patients and doctors about potentially serious side effects, including gastroparesis or stomach paralysis, and bowel obstruction
GLP-1 medications have generally been well-tolerated for long-term use, though they may have mild to moderate side effects such as nausea, vomiting, diarrhea, abdominal discomfort, or occasional constipation
That said, adopting lifestyle strategies while taking a GLP-1 might help to reduce the risk of regain
Its a promising, emerging area of medicine